期刊
INTERNATIONAL JOURNAL OF PHARMACEUTICS
卷 469, 期 1, 页码 132-139出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ijpharm.2014.04.042
关键词
Inhalation; Dry powder inhaler; Capreomycin; Tuberculosis; Lung administration
The aim of the work was to produce inhalable capreomycin powders using a novel spray-drying technology. A 2(3) factorial design was used to individuate the best working conditions. The maximum desirability was identified at the smallest mean volume diameter (d(v)) and span, and the highest yield. Powders were characterized for size, morphology, flowability and aerodynamic properties. Mathematical models showed a good predictivity with biases lower than 20%. The maximum conformity with desirability criteria was obtained spraying a 10 mg/mL bacitracin solution at 111 degrees C with the 4 mm pore size membrane. By processing capreomycin sulfate with the parameters optimized for bacitracin, an inhalable powder was obtained (i.e., yield of 82%, d(v) of 3.83 mu m, and span of 1.04). By further optimization, capreomycin sulfate powder characteristics were improved (i.e., yield, similar to 71%; dv, 3.25 mm; span, 0.95). After formulation with lactose, emitted dose and respirable fraction of 87% and similar to 27% were obtained, respectively. Two capreomycin sulfate powders with suitable properties for inhalation were produced using the nano spray-dryer B-90. (C) 2014 Elsevier B. V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据